Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9929)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2014 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bilici A. Treatment options in patients with metastatic gastric cancer: Current status and future perspectives. World J Gastroenterol 2014; 20(14): 3905-3915 [PMID: 24744580 DOI: 10.3748/wjg.v20.i14.3905] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i14/3905.htm |
| Number | Citing Articles |
| 1 |
Russell Petty, Alan Anthoney, Jean-Philippe Metges, Maria Alsina, Anthony Gonçalves, Jennifer Brown, Clara Montagut, Katharina Gunzer, Gianluca Laus, Jorge Luis Iglesias Dios, Bernardo Miguel-Lillo, Patrick Bohan, Ramón Salazar. Phase Ib/II study of elisidepsin in metastatic or advanced gastroesophageal cancer (IMAGE trial). Cancer Chemotherapy and Pharmacology 2016; 77(4): 819 doi: 10.1007/s00280-016-2991-0
|
| 2 |
Ramakrishnan Ayloor Seshadri, Olivier Glehen. The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer. Indian Journal of Surgical Oncology 2016; 7(2): 198 doi: 10.1007/s13193-016-0502-8
|
| 3 |
Hao-Chien Hung, Po-Jung Hsu, Chao-Wei Lee, Jun-Te Hsu, Ting-Jung Wu. Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Peritoneal Carcinomatosis: Additional Information Helps to Optimize Patient Selection before Surgery. Cancers 2023; 15(7): 2089 doi: 10.3390/cancers15072089
|
| 4 |
Esat Namal, Candas Ercetin, Merve Tokocin, Zafer Akcali, Hakan Yigitbas, Erkan Yavuz, Fatih Celebi, Tolga Totoz, Ozgul Pamukcu, Emel Saglam. Survival Effect of Supportive Care Services for Turkish Patients with Metastatic Gastric Cancer. Asian Pacific Journal of Cancer Prevention 2015; 16(3): 1213 doi: 10.7314/APJCP.2015.16.3.1213
|
| 5 |
Chan Kim, Hong Jae Chon, Joo Hoon Kim, Minkyu Jung, Chung Mo Nam, Hyo Song Kim, Beodeul Kang, Hyun Cheol Chung, Sun Young Rha. Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer. European Journal of Cancer 2019; 112: 20 doi: 10.1016/j.ejca.2018.11.029
|
| 6 |
Jishui Zhang, Wenhao Lv, Yagang Liu, Weihua Fu, Baosheng Chen, Qiutong Ma, Xin Gao, Xiuxia Cui. Nucleoporin 37 promotes the cell proliferation, migration, and invasion of gastric cancer through activating the PI3K/AKT/mTOR signaling pathway. In Vitro Cellular & Developmental Biology - Animal 2021; 57(10): 987 doi: 10.1007/s11626-021-00627-w
|
| 7 |
Minyu Zhou, Shuhan Liu, Yaqi Jiang, Huanrong Ma, Min Shi, Quanshi Wang, Wen Zhong, Wangjun Liao, Malcolm M. Q. Xing. Doxorubicin‐Loaded Single Wall Nanotube Thermo‐Sensitive Hydrogel for Gastric Cancer Chemo‐Photothermal Therapy. Advanced Functional Materials 2015; 25(29): 4730 doi: 10.1002/adfm.201501434
|
| 8 |
Amin Azarnoosh, Elahe Farmani, Farzaneh Niki Boroujeni, Elham Nazar. Evaluation of the Her-2/neu value in papillary thyroid carcinoma and its relation to histopathological prognostic findings. Cancer Treatment and Research Communications 2024; 41: 100840 doi: 10.1016/j.ctarc.2024.100840
|
| 9 |
E Schmid, M Klotz, K Steiner-Hahn, T Konen, AL Frisk, C Schatz, T Krahn, O von Ahsen. Detection of MET mRNA in gastric cancer in situ. Comparison with immunohistochemistry and sandwich immunoassays. Biotechnic & Histochemistry 2017; 92(6): 425 doi: 10.1080/10520295.2017.1339913
|
| 10 |
Y. Tan, W. Li, Y. Chen, Y. Deng, J. Xiao. Bi-weekly docetaxel and 5-fluorouracil: an effective and feasible treatment for advanced gastric cancer with poor performance status. Gastroenterology Report 2014; 2(4): 295 doi: 10.1093/gastro/gou051
|
| 11 |
Samana Batool, Thomson Patrick Joseph, Mushraf Hussain, Miza S. Vuai, Kavish. H. Khinsar, Syed Riaz Ud Din, Arshad Ahmed Padhiar, Mintao Zhong, Anhong Ning, Wei Zhang, Jing Cao, Min Huang. LP1 from Lentinula edodes C91-3 Induces Autophagy, Apoptosis and Reduces Metastasis in Human Gastric Cancer Cell Line SGC-7901. International Journal of Molecular Sciences 2018; 19(10): 2986 doi: 10.3390/ijms19102986
|
| 12 |
Wenhan Li, Yao Tang, Danfang Wang, Jianhui Li. Outcomes in patients with metastatic gastric cancer: a surveillance, epidemiology, and end results program (SEER) database analysis. All Life 2023; 16(1) doi: 10.1080/26895293.2023.2288532
|
| 13 |
Cristina Rihuete Caro, Israel Manzanedo, Fernando Pereira, Lucía Carrion-Alvarez, Ángel Serrano, Estíbalitz Pérez-Viejo. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis. European Journal of Surgical Oncology 2018; 44(11): 1805 doi: 10.1016/j.ejso.2018.06.036
|
| 14 |
Jaeyoung Lim, Ji Hyeon Ryu, Eun-Jin Kim, Songhee Ham, Dawon Kang. Inhibition of Vascular Endothelial Growth Factor Receptor 3 Reduces Migration of Gastric Cancer Cells. Cancer Investigation 2015; 33(8): 398 doi: 10.3109/07357907.2015.1047509
|
| 15 |
Riccardo Dolcetti, Valli De Re. Gastric Cancer In The Precision Medicine Era. Current Clinical Pathology 2019; : 189 doi: 10.1007/978-3-030-04861-7_12
|
| 16 |
Renato Santos Laboissiere, Marcelo Araújo Buzelin, Débora Balabram, Marina De Brot, Cristiana Buzelin Nunes, Rafael Malagoli Rocha, Mônica Maria Demas Álvares Cabral, Helenice Gobbi. Association between HER2 status in gastric cancer and clinicopathological features: a retrospective study using whole-tissue sections. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0384-1
|
| 17 |
Sergei A. Tjulandin, Alexey A. Tryakin, Natalia S. Besova, Evgeniya Sholokhova, Jasmina I. Ivanova, Wendy Y. Cheng, Luke M. Schmerold, Philippe Thompson-Leduc, Diego Novick. Real-world treatment patterns among patients with advanced gastric cancer in Russia: a chart review study. Journal of Drug Assessment 2019; 8(1): 150 doi: 10.1080/21556660.2019.1669610
|
| 18 |
JITSUKO TAKANO, ASAHIRO MORISHITA, SHINTARO FUJIHARA, HISAKAZU IWAMA, FUYUKO KOKADO, KEIKO FUJIKAWA, KOJI FUJITA, TAIGA CHIYO, TOMOKO TADOKORO, TEPPEI SAKAMOTO, TAKAKO NOMURA, JOJI TANI, HISAAKI MIYOSHI, HIROHITO YONEYAMA, HIDEKI KOBARA, HIROHITO MORI, TOSHIHIRO NIKI, MITSUOMI HIRASHIMA, TSUTOMU MASAKI. Galectin-9 suppresses the proliferation of gastric cancer cells in vitro. Oncology Reports 2016; 35(2): 851 doi: 10.3892/or.2015.4452
|
| 19 |
Massimo Framarini, Fabrizio D’Acapito, Daniela Di Pietrantonio, Francesca Tauceri, Giovanni Vittimberga, Leonardo Solaini, Giulia Elena Cantelli, Giulia Marchetti, Paolo Morgagni, Giorgio Ercolani. Advanced Gastric Cancer: Single-Center Experience. Surgeries 2024; 5(2): 465 doi: 10.3390/surgeries5020038
|
| 20 |
Jianxin Li, Xin Wang, Yinchun Wang, Qingqiang Yang.
H19
Promotes the Gastric Carcinogenesis by Sponging
miR-29a-3p
: Evidence from lncRNA–miRNA–mRNA Network Analysis
. Epigenomics 2020; 12(12): 989 doi: 10.2217/epi-2020-0114
|
| 21 |
Giulia Accordino, Sara Lettieri, Chandra Bortolotto, Silvia Benvenuti, Anna Gallotti, Elisabetta Gattoni, Francesco Agustoni, Emma Pozzi, Pietro Rinaldi, Cristiano Primiceri, Patrizia Morbini, Andrea Lancia, Giulia Maria Stella. From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers—A Multidisciplinary Perspective. Cancers 2020; 12(8): 2105 doi: 10.3390/cancers12082105
|
| 22 |
Maryam Fatehi-Agdam, Mohammad Amin Vatankhah, Reza Panahizadeh, Farhad Jeddi, Nowruz Najafzadeh. Efficacy of Metformin and Chemotherapeutic Agents on the Inhibition of Colony Formation and Shh/Gli1 Pathway: Metformin/Docetaxel Versus Metformin/5-Fluorouracil. Drug Research 2021; 71(01): 17 doi: 10.1055/a-1248-9008
|
| 23 |
Claramae Shulyn Chia, Ramakrishnan Ayloor Seshadri, Vahan Kepenekian, Delphine Vaudoyer, Guillaume Passot, Olivier Glehen. Survival outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from gastric cancer: a systematic review. Pleura and Peritoneum 2016; 1(2): 67 doi: 10.1515/pp-2016-0010
|
| 24 |
Jessica J. Miller, Christophe Orvain, Shireen Jozi, Ryan M. Clarke, Jason R. Smith, Anaïs Blanchet, Christian Gaiddon, Jeffrey J. Warren, Tim Storr. Multifunctional Compounds for Activation of the p53‐Y220C Mutant in Cancer. Chemistry – A European Journal 2018; 24(67): 17734 doi: 10.1002/chem.201802677
|
| 25 |
Florian Lordick, Peter Thuss-Patience, Michael Bitzer, Daniel Maurus, Ugur Sahin, Özlem Türeci. Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(9): 5937 doi: 10.1007/s00432-022-04459-3
|
| 26 |
Riccardo Dolcetti, Valli De Re, Vincenzo Canzonieri. Immunotherapy for Gastric Cancer: Time for a Personalized Approach?. International Journal of Molecular Sciences 2018; 19(6): 1602 doi: 10.3390/ijms19061602
|
| 27 |
Naziha Mansuri, Eva-Maria Birkman, Vanina D. Heuser, Minnamaija Lintunen, Annika Ålgars, Jari Sundström, Raija Ristamäki, Laura Lehtinen, Olli Carpén. Association of tumor-infiltrating T lymphocytes with intestinal-type gastric cancer molecular subtypes and outcome. Virchows Archiv 2021; 478(4): 707 doi: 10.1007/s00428-020-02932-3
|
| 28 |
Antonio Macrì, Federico Morabito. The use of intraperitoneal chemotherapy for gastric malignancies. Expert Review of Anticancer Therapy 2019; 19(10): 879 doi: 10.1080/14737140.2019.1671189
|
| 29 |
Hae Young Kim, Young Hoon Kim, Gabin Yun, Won Chang, Yoon Jin Lee, Bohyoung Kim, Amber L. Simpson. Could texture features from preoperative CT image be used for predicting occult peritoneal carcinomatosis in patients with advanced gastric cancer?. PLOS ONE 2018; 13(3): e0194755 doi: 10.1371/journal.pone.0194755
|
| 30 |
Israel Manzanedo, Fernando Pereira, Estíbalitz Pérez-Viejo, Ángel Serrano. Gastric Cancer with Peritoneal Metastases: Current Status and Prospects for Treatment. Cancers 2023; 15(6): 1777 doi: 10.3390/cancers15061777
|
| 31 |
Francisca Ramalho-Vasconcelos, Raquel Gomes, Raquel Bouça-Machado, Marisa Aral, Jorge Nogueiro, Tiago Bouça-Machado, Bernardo Sousa-Pinto, Hugo Santos-Sousa. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in the Treatment of Gastric Cancer: Feasibility, Efficacy and Safety—A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2024; 13(11): 3320 doi: 10.3390/jcm13113320
|
| 32 |
Chunxiang Cao, Xunlei Zhang, Meng Kuang, Dongying Gu, Mingliang He, Jinfei Chen, Cuiju Tang. Survival benefit from S‐1 as compared to Fluorouracil in Asian patients with advanced gastrointestinal cancer: A meta‐analysis. Cancer Science 2014; 105(8): 1008 doi: 10.1111/cas.12465
|
| 33 |
Juan Wang, Dong Xue Wu, Lu Meng, Gang Ji. Anlotinib combined with SOX regimen (S1 (tegafur, gimeracil and oteracil porassium capsules) + oxaliplatin) in treating stage IV gastric cancer: study protocol for a single-armed and single-centred clinical trial. BMJ Open 2020; 10(6): e034685 doi: 10.1136/bmjopen-2019-034685
|
| 34 |
Batoul Farran, Susanne Müller, Raquel C Montenegro. Gastric cancer management: Kinases as a target therapy. Clinical and Experimental Pharmacology and Physiology 2017; 44(6): 613 doi: 10.1111/1440-1681.12743
|
| 35 |
Xiaojing Deng, Hailun Zheng, Dapeng Li, Yongju Xue, Qizhi Wang, Shanjun Yan, Yu Zhu, Min Deng. MicroRNA-34a regulates proliferation and apoptosis of gastric cancer cells by targeting silent information regulator 1. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.5920
|
| 36 |
Lev D. Bubis, Victoria Delibasic, Laura E. Davis, Yunni Jeong, Kelvin Chan, Ekaterina Kosyachkova, Alyson Mahar, Paul Karanicolas, Natalie G. Coburn. Patient-reported symptoms in metastatic gastric cancer patients in the last 6 months of life. Supportive Care in Cancer 2021; 29(1): 515 doi: 10.1007/s00520-020-05501-1
|
| 37 |
Jun Huang, Yongzhao Zhao, Yong Xu, Yanjie Zhu, Jiale Huang, Yanna Liu, Liying Zhao, Zhijia Li, Hao Liu, Qi-long Wang, Xiaolong Qi. Comparative effectiveness and safety between oxaliplatin-based and cisplatin-based therapy in advanced gastric cancer: A meta-analysis of randomized controlled trials. Oncotarget 2016; 7(23): 34824 doi: 10.18632/oncotarget.9189
|
| 38 |
Dagmar Brančíková, Michal Eid. News in systemic treatment of advanced and metastatic carcinoma of the stomach. Klinická farmakologie a farmacie 2018; 32(3): 15 doi: 10.36290/far.2018.018
|
| 39 |
Ruizhong Wang, Hua Fang, Qin Fang. Downregulation of FKBP14 by RNA interference inhibits the proliferation, adhesion and invasion of gastric cancer cells. Oncology Letters 2017; 13(4): 2811 doi: 10.3892/ol.2017.5781
|
| 40 |
Megan Wheelden, Nelson s Yee. <p>Clinical Evaluation of the Safety and Efficacy of Trifluridine/Tipiracil in the Treatment of Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Evidence to Date</p>. OncoTargets and Therapy 2020; : 7459 doi: 10.2147/OTT.S216598
|
| 41 |
Vinod Vijay Subhash, Shi Hui Tan, Woei Loon Tan, Mei Shi Yeo, Chen Xie, Foong Ying Wong, Zee Ying Kiat, Robert Lim, Wei Peng Yong. GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1550-0
|
| 42 |
TianTian Guo, YingNan Yu, George Wai‐Cheong Yip, Gyeong Hun Baeg, Aye Aye Thike, Tony Kiat‐Hon Lim, Puay Hoon Tan, Ken Matsumoto, Boon Huat Bay. Y‐box binding protein 1 is correlated with lymph node metastasis in intestinal‐type gastric cancer. Histopathology 2015; 66(4): 491 doi: 10.1111/his.12570
|
| 43 |
Jia-Qi Wu, Jing Zhai, Chong-Yong Li, Ai-Min Tan, Ping Wei, Li-Zong Shen, Ming-Fang He. Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer. Journal of Experimental & Clinical Cancer Research 2017; 36(1) doi: 10.1186/s13046-017-0631-0
|
| 44 |
Ofer Purim, Alexander Beny, Moshe Inbar, Katerina Shulman, Baruch Brenner, Elizabeth Dudnik, Felix Bokstein, Mark Temper, Dror Limon, Diana Matceyevsky, David Sarid, Amiel Segal, Valeriya Semenisty, Ronen Brenner, Tamar Peretz, Efraim Idelevich, Sharon Pelles-Avraham, Amichay Meirovitz, Arie Figer, Kenneth Russell, Andreas Voss, Addie Dvir, Lior Soussan-Gutman, Ayala Hubert. Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience. Targeted Oncology 2018; 13(2): 217 doi: 10.1007/s11523-017-0548-8
|
| 45 |
Jaqueline de Freitas Rodrigues, Hellen Kempfer Philippsen, Maria Fani Dolabela, Cleusa Yoshiko Nagamachi, Julio Cesar Pieczarka. The Potential of DHA as Cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials. Nutrients 2023; 15(8): 2006 doi: 10.3390/nu15082006
|
| 46 |
Kyoung-Min Choi, Boram Kim, Su-Min Lee, Jisoo Han, Ha-Song Bae, Su-Bhin Han, Dagyeong Lee, In-Hye Ham, Hoon Hur, Eunjung Kim, Jae-Young Kim. Characterization of gastric cancer-stimulated signaling pathways and function of CTGF in cancer-associated fibroblasts. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-023-01396-7
|
| 47 |
Sidhartha Kalra, Ramanitharan Manikandan, Lalgudi Narayanan Dorairajan, Bhavana Badhe. Synchronously detected secondary signet ring cell urinary bladder malignancy from the stomach masquerading as genitourinary tuberculosis. BMJ Case Reports 2015; : bcr2014206120 doi: 10.1136/bcr-2014-206120
|
| 48 |
Hee Jeong Cho, Hye Jin Jung. Cyclophilin A Inhibitors Suppress Proliferation and Induce Apoptosis of MKN45 Gastric Cancer Stem-like Cells by Regulating CypA/CD147-Mediated Signaling Pathway. International Journal of Molecular Sciences 2023; 24(5): 4734 doi: 10.3390/ijms24054734
|
| 49 |
Gustavo dos Santos Fernandes, Daniel da Motta Girardi, Luiza Dib Batista Bugiato Faria, João Paulo Giacomini Bernardes, Renata de Almeida Coudry. Impressive response to immunotherapy in a metastatic gastric cancer patient: could somatic copy number alterations help patient selection?. Journal for ImmunoTherapy of Cancer 2017; 5(1) doi: 10.1186/s40425-017-0291-9
|
| 50 |
Yin Jin, Liping Tao, Shuqing Jin, Weiyang Cai. Patterns of immune infiltration in gastric cancer and their clinical significance. Japanese Journal of Clinical Oncology 2021; 51(7): 1067 doi: 10.1093/jjco/hyab054
|
| 51 |
Hung‐Sheng Shang, Hsu‐Feng Lu, Ching‐Hsiao Lee, Han‐Sun Chiang, Yung‐Lin Chu, Ann Chen, Yuh‐Feng Lin, Jing‐Gung Chung. Quercetin induced cell apoptosis and altered gene expression in AGS human gastric cancer cells. Environmental Toxicology 2018; 33(11): 1168 doi: 10.1002/tox.22623
|
| 52 |
Pedro Nazareth Junior Aguiar, Christian Ribas, Nora Manoukian Forones. Individualized Chemotherapy for Metastatic Gastric Cancer: Retrospective Data from a University Hospital in Brazil. Asian Pacific Journal of Cancer Prevention 2015; 16(13): 5289 doi: 10.7314/APJCP.2015.16.13.5289
|
| 53 |
Jian He, Hua Shi, Zhuping Zhou, Jun Chen, Wenxian Guan, Hao Wang, Haiping Yu, Song Liu, Zhengyang Zhou, Xiaofeng Yang, Tian Liu. Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1726-7
|
| 54 |
Ramakrishnan Ayloor Seshadri, Olivier Glehen. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer. World Journal of Gastroenterology 2016; 22(3): 1114-1130 doi: 10.3748/wjg.v22.i3.1114
|
| 55 |
Lixia Zhou, Yueming Wu, Yang Guo, Yanjun Li, Na Li, Yi Yang, Xueyun Qin. Calycosin Enhances Some Chemotherapeutic Drugs Inhibition of Akt Signaling Pathway in Gastric Cells. Cancer Investigation 2017; 35(5): 289 doi: 10.1080/07357907.2016.1278226
|
| 56 |
Yong‐Ming He, Chen Yu, Wei‐Bing Li, Zhi‐Peng Li, Nan Xu. Evaluation of short‐term effectiveness of eight targeted agents combined with chemotherapy for treating esophageal‐gastric junction adenocarcinoma: A network meta‐analysis. Journal of Cellular Biochemistry 2018; 119(1): 1183 doi: 10.1002/jcb.26288
|
| 57 |
Yasutoshi Kuboki, Christoph A. Schatz, Karl Koechert, Sabine Schubert, Janine Feng, Sabine Wittemer-Rump, Karl Ziegelbauer, Thomas Krahn, Akiko Kawano Nagatsuma, Atsushi Ochiai. In situ analysis of FGFR2 mRNA and comparison with FGFR2 gene copy number by dual-color in situ hybridization in a large cohort of gastric cancer patients. Gastric Cancer 2018; 21(3): 401 doi: 10.1007/s10120-017-0758-x
|
| 58 |
Kate McKeage. Nanosomal Docetaxel Lipid Suspension: A Guide to Its Use in Cancer. Clinical Drug Investigation 2017; 37(4): 405 doi: 10.1007/s40261-017-0510-7
|
| 59 |
Wei Li, Ying Zhou, Jin Yang, Xu Zhang, Huanhuan Zhang, Ting Zhang, Shaolin Zhao, Ping Zheng, Juan Huo, Huiyi Wu. Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8. Journal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0172-3
|
| 60 |
Xuefen Lei, Feng Wang, Yang Ke, Dong Wei, Hou Gu, Zhixian Zhang, Lifeng Jiang, Li Lv, Jie Lin, Lin Wang. The role of antiangiogenic agents in the treatment of gastric cancer. Medicine 2017; 96(10): e6301 doi: 10.1097/MD.0000000000006301
|
| 61 |
Meenakshi Patyal, Kirandeep Kaur, Neeraj Bala, Nidhi Gupta, Ashok Kumar Malik. Innovative lanthanide complexes: Shaping the future of cancer/ tumor chemotherapy. Journal of Trace Elements in Medicine and Biology 2023; 80: 127277 doi: 10.1016/j.jtemb.2023.127277
|
| 62 |
Angela Buonadonna, Gian Maria Miolo, Valentina Fanotto, Federico Navarria, Elisa Palazzari, Claudio Belluco, Stefania Maiero, Vincenzo Canzonieri, Giulio Bertola, Antonino De Paoli. Gastric Cancer In The Precision Medicine Era. Current Clinical Pathology 2019; : 121 doi: 10.1007/978-3-030-04861-7_7
|
| 63 |
Lixiang Zhang, Baichuan Zhou, Panquan Luo, Aman Xu, Wenxiu Han, Zhijian Wei. A model established using marital status and other factors from the Surveillance, Epidemiology, and End Results database for early stage gastric cancer. Journal of Investigative Medicine 2022; 70(6): 1373 doi: 10.1136/jim-2021-002285
|
| 64 |
Naoki Takahashi, Koh Furuta, Hirokazu Taniguchi, Yusuke Sasaki, Hirokazu Shoji, Yoshitaka Honma, Satoru Iwasa, Natsuko Okita, Atsuo Takashima, Ken Kato, Tetsuya Hamaguchi, Yasuhiro Shimada, Yasuhide Yamada. Serum level of hepatocyte growth factor is a novel marker of predicting the outcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancer. Oncotarget 2016; 7(4): 4925 doi: 10.18632/oncotarget.6753
|
| 65 |
Hee Jeong Cho, Hye Jin Jung. Cyclophilin A knockdown inhibits the proliferation and metastatic ability of AGS gastric cancer stem cells by downregulating CD147/STAT3/AKT/ERK and epithelial‑mesenchymal transition. Molecular Medicine Reports 2024; 31(1) doi: 10.3892/mmr.2024.13379
|
| 66 |
FEI YUAN, HAILONG SHI, JUN JI, QU CAI, XUEHUA CHEN, YINGYAN YU, BINGYA LIU, ZHENGGANG ZHU, JUN ZHANG. Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesis. Oncology Reports 2015; 33(4): 1753 doi: 10.3892/or.2015.3765
|
| 67 |
Rilan Bai, Naifei Chen, Tingting Liang, Lingyu Li, Zheng Lv, Xiaomin Lv, Jiuwei Cui. Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00912
|